2017 Vol.35, N°6 - Table of contents
November-December 2017
Review
CER10835
2017,35,6
Pg. 0875-0884
Free to view
One year in review 2017: idiopathic inflammatory myopathies
S. Barsotti, C. Bruni, L. Cometi, V. Valentini, E. Cioffi, R. Neri, L. Cavagna
S. Barsotti, C. Bruni, L. Cometi, V. Valentini, E. Cioffi, R. Neri, L. Cavagna
Full Papers
CER9913
2017,35,6
Pg. 0885-0892
Free to view
Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis
H. Sánchez-Pérez, B. Tejera-Segura, A. De vera-González, A. González-Delgado, J.M. Olmos, J.L. Hernández, A. Corrales, R. López-Mejías, M.A. González-Gay, I. Ferraz-Amaro
H. Sánchez-Pérez, B. Tejera-Segura, A. De vera-González, A. González-Delgado, J.M. Olmos, J.L. Hernández, A. Corrales, R. López-Mejías, M.A. González-Gay, I. Ferraz-Amaro
CER9872
2017,35,6
Pg. 0893-0898
Obesity does not diminish the efficacy of IL-6 signalling blockade in mice with collagen-induced arthritis
M. Suzuki, K. Tanaka, H. Yoshida, K. Yogo, Y. Matsumoto
M. Suzuki, K. Tanaka, H. Yoshida, K. Yogo, Y. Matsumoto
CER10034
2017,35,6
Pg. 0899-0906
Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies
B. Haraoui, G. Casado, L. Czirják, A. Taylor, C. Bernasconi, W. Reiss, R. Caporali
B. Haraoui, G. Casado, L. Czirják, A. Taylor, C. Bernasconi, W. Reiss, R. Caporali
CER10249
2017,35,6
Pg. 0907-0912
Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia
E. Donges, C.E. Staatz, H. Benham, P. Kubler, S.A. Hollingworth
E. Donges, C.E. Staatz, H. Benham, P. Kubler, S.A. Hollingworth
CER9916
2017,35,6
Pg. 0913-0918
Free to view
High incidence of vertebral osteoporotic fracture within the first year after liver transplantation
S. Butin, I. Griffoul, F. Espitalier, E. Salamé, D. Mulleman, P. Goupille
S. Butin, I. Griffoul, F. Espitalier, E. Salamé, D. Mulleman, P. Goupille
CER8496
2017,35,6
Pg. 0919-0928
Free to view
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study
R. Caporali, L. Idolazzi, S. Bombardieri, G. Ferraccioli, R. Gerli, M. Govoni, M. Matucci Cerinic, G. Pomponio, F. Salaffi, R. Tirri, F. Benaglio, L. Bianchino, P. Sarzi-Puttini
on behalf of TRUST study investigators.
R. Caporali, L. Idolazzi, S. Bombardieri, G. Ferraccioli, R. Gerli, M. Govoni, M. Matucci Cerinic, G. Pomponio, F. Salaffi, R. Tirri, F. Benaglio, L. Bianchino, P. Sarzi-Puttini
on behalf of TRUST study investigators.
CER9952
2017,35,6
Pg. 0929-0935
Free to view
The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic
N. Agmon-Levin, A. Dagan, Y. Peri, J.-M. Anaya, C. Selmi, A. Tincani, N. Bizzaro, L. Stojanovich, J. Damoiseaux, J.W. Cohen Tervaert, M. Mosca, R. Cervera, Y. Shoenfeld
N. Agmon-Levin, A. Dagan, Y. Peri, J.-M. Anaya, C. Selmi, A. Tincani, N. Bizzaro, L. Stojanovich, J. Damoiseaux, J.W. Cohen Tervaert, M. Mosca, R. Cervera, Y. Shoenfeld
CER10012
2017,35,6
Pg. 0936-0942
DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort
U. Lindqvist, M.-L. Wernroth, T. Husmark, P. Larsson, M. Geijer, A. Teleman, E. Theander, G.-M. Alenius
U. Lindqvist, M.-L. Wernroth, T. Husmark, P. Larsson, M. Geijer, A. Teleman, E. Theander, G.-M. Alenius
CER10116
2017,35,6
Pg. 0943-0947
Free to view
Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules
E.L. Houlder, M.J. Millier, J. Highton, D. Gwynne-Jones, L.K. Stamp, P.A. Hessian
E.L. Houlder, M.J. Millier, J. Highton, D. Gwynne-Jones, L.K. Stamp, P.A. Hessian
CER10194
2017,35,6
Pg. 0948-0953
Anti-homocitrullinated protein antibody isotype usage in rheumatoid arthritis and their unaffected first-degree relatives
D.A. Bell, S. Elhayek, E. Cairns, L. Barra
D.A. Bell, S. Elhayek, E. Cairns, L. Barra
CER10181
2017,35,6
Pg. 0954-0958
Free to view
Evaluation of non-contrast MRI biomarkers in lupus nephritis
S. Skeoch, P.L. Hubbard Cristinacce, M. Dobbs, J. Naish, N. Woodhouse, M. Ho, J.C. Waterton, G.J. Parker, I.N. Bruce
S. Skeoch, P.L. Hubbard Cristinacce, M. Dobbs, J. Naish, N. Woodhouse, M. Ho, J.C. Waterton, G.J. Parker, I.N. Bruce
CER10281
2017,35,6
Pg. 0959-0965
Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation
H.B. Hammer, T.K. Kvien, L. Terslev
H.B. Hammer, T.K. Kvien, L. Terslev
CER10283
2017,35,6
Pg. 0966-0974
Free to view
Preclinical biomarker associations with both incident rheumatoid arthritis and its subsequent mortality: sex effects in a 41-year, community-based, case-control cohort study
A.T. Masi, A.A. Rehman, L.C. Jorgenson, J.C. Aldag
A.T. Masi, A.A. Rehman, L.C. Jorgenson, J.C. Aldag
CER10284
2017,35,6
Pg. 0975-0982
Health care utilisation before and after intensive care unit admission in rheumatoid arthritis
R.A. Marrie, C.A. Hitchon, C.A. Peschken, H. Chen, C.N. Bernstein, A. Garland
R.A. Marrie, C.A. Hitchon, C.A. Peschken, H. Chen, C.N. Bernstein, A. Garland
CER10123
2017,35,6
Pg. 0983-0990
Genome-wide expression and methylation profiling reveal candidate genes in osteoarthritis
Y. Fan, J. Chen, Y. Yang, J. Lin, Z. Wu
Y. Fan, J. Chen, Y. Yang, J. Lin, Z. Wu
CER10565
2017,35,6
Pg. 0991-1010
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology
A. Marchesoni, I. Olivieri, C. Salvarani, N. Pipitone, S. D'angelo, A. Mathieu, A. Cauli, L. Punzi, R. Ramonda, R. Scarpa, M. Maccarone, E. Lubrano
A. Marchesoni, I. Olivieri, C. Salvarani, N. Pipitone, S. D'angelo, A. Mathieu, A. Cauli, L. Punzi, R. Ramonda, R. Scarpa, M. Maccarone, E. Lubrano
Brief Papers
CER10268
2017,35,6
Pg. 1011-1013
Free to view
Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity
R.C. De Souza, F.H. De Souza, R. Miossi, S.K. Shinjo
R.C. De Souza, F.H. De Souza, R. Miossi, S.K. Shinjo
CER10309
2017,35,6
Pg. 1014-1017
Free to view
Opioid use in patients with polymyalgia rheumatica
M.D. Richter, S.J. Achenbach, J.A. Zamora-Legoff, C.S. Crowson, E.L. Matteson
M.D. Richter, S.J. Achenbach, J.A. Zamora-Legoff, C.S. Crowson, E.L. Matteson
Review
CER10179
2017,35,6
Pg. 1018-1028
Free to view
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis
M. Galli, S. Antinori, F. Atzeni, L. Meroni, A. Riva, C.A. Scirè, F. Adorni, L. Quartuccio, M. Sebastiani, P. Airò, L. Bazzichi, F. Cristini, V. Del Bono, A. Manfredi, O. Viapiana, F. De Rosa, E. Favalli, E. Petrelli, C. Salvarani, M. Govoni, S. Corcione, R. Scrivo, L. Sarmati, A. Lazzarin, W. Grassi, C. Mastroianni, G.B. Gaeta, G. Ferraccioli, M. Cutolo, S. De Vita, G. Lapadula, M. Matucci-Cerinic, O. Armignacco, P. Sarzi-Puttini
M. Galli, S. Antinori, F. Atzeni, L. Meroni, A. Riva, C.A. Scirè, F. Adorni, L. Quartuccio, M. Sebastiani, P. Airò, L. Bazzichi, F. Cristini, V. Del Bono, A. Manfredi, O. Viapiana, F. De Rosa, E. Favalli, E. Petrelli, C. Salvarani, M. Govoni, S. Corcione, R. Scrivo, L. Sarmati, A. Lazzarin, W. Grassi, C. Mastroianni, G.B. Gaeta, G. Ferraccioli, M. Cutolo, S. De Vita, G. Lapadula, M. Matucci-Cerinic, O. Armignacco, P. Sarzi-Puttini
CER10240
2017,35,6
Pg. 1029-1036
Free to view
Prevalence and risk factors for liver fibrosis detected by transient elastography or shear wave elastography in inflammatory arthritis: a systematic review
A. Rouhi, G. Hazlewood, A.-A. Shaheen, M.G. Swain, C.E. Barber
A. Rouhi, G. Hazlewood, A.-A. Shaheen, M.G. Swain, C.E. Barber
CER10605
2017,35,6
Pg. 1037-1042
Olfactory dysfunction and autoimmunity: pathogenesis and new insights
O. Shamriz, Y. Shoenfeld
O. Shamriz, Y. Shoenfeld
Paediatric Rheumatology
CER9793
2017,35,6
Pg. 1043-1046
Free to view
Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis
S.T. Leinonen, K. Aalto, K.M. Kotaniemi, T.T. Kivelä
S.T. Leinonen, K. Aalto, K.M. Kotaniemi, T.T. Kivelä
CER10275
2017,35,6
Pg. 1047-1055
Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
V. Torrente-Segarra, T.C. Salman Monte, I. Rúa-Figueroa, F. Sánchez-Alonso, F.J. López-Longo, M. Galindo-Izquierdo, J. Calvo-Alén, A. Olivé-Marqués, J. Ibañez-Ruán, L. Horcada, A. Sánchez-Atrio, C. Montilla, R.B. Melero González, E. Díez-Álvarez, V. Martinez-Taboada, J.L. Andreu, O. Fernández-Berrizbeitia, J.Á. Hernández-Beriain, M. Gantes, B. Hernández-Cruz, Á. Pecondón-Español, C. Marras, G. Bonilla, J.M. Pego-Reigosa
on behalf of the RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).
V. Torrente-Segarra, T.C. Salman Monte, I. Rúa-Figueroa, F. Sánchez-Alonso, F.J. López-Longo, M. Galindo-Izquierdo, J. Calvo-Alén, A. Olivé-Marqués, J. Ibañez-Ruán, L. Horcada, A. Sánchez-Atrio, C. Montilla, R.B. Melero González, E. Díez-Álvarez, V. Martinez-Taboada, J.L. Andreu, O. Fernández-Berrizbeitia, J.Á. Hernández-Beriain, M. Gantes, B. Hernández-Cruz, Á. Pecondón-Español, C. Marras, G. Bonilla, J.M. Pego-Reigosa
on behalf of the RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).
Letters to the Editor
CER10360
2017,35,6
Pg. 1056
Free to view
Efficacy of belimumab for the long-term maintenance therapy of thrombocytopenia in systemic lupus erythematosus
G. De Marchi, L. Quartuccio, M. Bond, S. De Vita
G. De Marchi, L. Quartuccio, M. Bond, S. De Vita
CER10410
2017,35,6
Pg. 1057-1058
Free to view
Rapidly progressive lung disease in a patient with signs of clinically amyopathic dermatomyositis
E. Zampeli, F.N. Skopouli, A. Athanasakos, H.M. Moutsopoulos
E. Zampeli, F.N. Skopouli, A. Athanasakos, H.M. Moutsopoulos